Show
Sort by
-
- Journal Article
- A1
- open access
A novel carbohydrate fatty-acid monosulphate ester, squalane-in-water adjuvant is safe and enhances inactivated influenza vaccine immunogenicity in older adults
-
- Journal Article
- A1
- open access
Safety and immunogenicity of an adjuvanted clostridioides difficile vaccine candidate in healthy adults : a randomized placebo-controlled phase 1 study
-
- Journal Article
- A1
- open access
Safety and immunogenicity of a 4-component generalized modules for membrane antigens Shigella vaccine in healthy European adults : randomized, phase 1/2 study
-
- Journal Article
- A1
- open access
Evaluation of safety, immunogenicity and cross-reactive immunity of OVX836, a nucleoprotein-based universal influenza vaccine, in older adults
-
- Journal Article
- A1
- open access
Safety and immunogenicity of a carbohydrate fatty acid monosulphate ester adjuvant combined with a low-dose quadrivalent split-virion inactivated influenza vaccine : a randomised, observer-blind, active-controlled, first-in-human, phase 1 study
-
- Journal Article
- A1
- open access
Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults : a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial
-
- Journal Article
- A1
- open access
Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate : a randomised, double-blind, placebo-controlled, phase 2a trial